Patients on a DOAC regimen had a higher risk of major bleeding, although the difference did not reach statistical significance (RR, 1.17; 95% CI, 0.82–1.67; p = 0.39.
← all excerpts
Factor XI and Cancer: Physiopathological Linkage and Clinical Perspectives.
1
0.3900
0.3900